The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
Ryght AI tackles these hurdles with its AI Site Twin platform
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The drug is currently being evaluated in two fully recruited global Phase 3 studies for progressive and tophaceous gout, with results expected in 2026.
Subscribe To Our Newsletter & Stay Updated
